Selective Visualization of Cyclooxygenase-2 in Inflammation and Cancer by Targeted Fluorescent Imaging Agents
Year: 2010
Type: article
Abstract: Effective diagnosis of inflammation and cancer by molecular imaging is challenging because of interference from nonselective accumulation of the contrast agents in normal tissues. Here, we report a series of novel fluorescence imaging agents that efficiently target cyclooxygenase-2 (COX-2), which is normally absent from cells, but is found at high levels in inflammatory lesions and in many premalignant and malignant tumors. After either i.p. or i.v. injection, these reagents become highly enriched in inflamed or tumor tissue compared with normal tissue and this accumulation provides sufficient signal for in vivo fluorescence imaging. Further, we show that only the intact parent compound is found in the region of interest. COX-2-specific delivery was unambiguously confirmed using animals bearing targeted deletions of COX-2 and by blocking the COX-2 active site with high-affinity inhibitors in both in vitro and in vivo models. Because of their high specificity, contrast, and detectability, these fluorocoxibs are ideal candidates for detection of inflammatory lesions or early-stage COX-2-expressing human cancers, such as those in the esophagus, oropharynx, and colon.
Source: Cancer Research
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Functional Analysis of Cyclooxygenase-2, Matrilsin and Tumor Progression, Multimodality Imaging of GI Cancers for Diagnosis and Directed Therapy, COX-2 Inhibitors, APC and Colon Cancer Prevention, Probes for Quantitative Optical and Electron Microscopy, Detection of Neoplasia in the Esophagus, South-Eastern Center for Imaging Animal Models of Cancer, VANDERBILT IN VIVO IMAGING CENTER, Cancer Center Support Grant
OpenAlex ID: W1964909390
